MIRA
INFORM REPORT
|
Report Date : |
14.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
INTERMED JAPAN INC |
|
|
|
|
Registered Office : |
SC Sakaisuji
Honmachi Bldg 9F, 1-4-15 Kitakyuhojimachi Chuoku Osaka 541-0057 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Date of Incorporation : |
Oct
1980 |
|
|
|
|
Legal Form : |
Limited
Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import
and wholesale of medical instruments |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Yen 141.3
millions |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name
INTERMED JAPAN INC
REGD NAME
KK
Intermed Japan
MAIN OFFICE
SC
Sakaisuji Honmachi Bldg 9F, 1-4-15 Kitakyuhojimachi Chuoku Osaka 541-0057 JAPAN
Tel : 06-6262-2481
Fax : 06-6262-7556
*.. See REGISTRATION for subsidiary JSS Inc
URL :
http://www.intermedjp.co.jp
E-Mail
address: info@intermedjp.co.jp
ACTIVITIES
Import,
wholesale of medical instruments
LICENSES
Medical Instruments Importer / distributor’s License : No. 27BY5059 since 01/Dec/1983; Medical Instruments Mfg License: No. 33BZ5002 since 12/Dec/1988; granted from the Ministry of Health, Labor & Welfare, Japan.
BRANCHES
Tokyo, Sapporo, Sendai, Niigata, Kanazawa, Nagoya, Hiroshima, Fukuoka, Takamatsu; (Overseas): San Diego (USA) (representative office)
FACTORY(IES)
Katsuta (Okayama-Pref): mfg, storing,
warehousing, tests & inspection, quality control, sterilizing, packing,
repairing, etc.
OFFICERS
KEN’ICHI
KANEMARU, PRES Yutaka Ono,
s/mgn dir
Keiji
Omata, mgn dir Yoshitaka
Hattori, dir
Mariko
Kura, dir Hideo
Gotoh, dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 3,300 M
PAYMENTS REGULAR CAPITAL Yen 30 M
TREND STEADY WORTH Yen
2,700 M
STARTED 1980 EMPLOYES 113
COMMENT
IMPORTER AND WHOLESALER OF MEDICAL
INSTRUMENTS. FINANCIAL SITUATION
CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 141.3 MILLION, 30 DAYS
NORMAL TERMS.
HIGHLIGHTS
The subject company was established by Ken’ichi
Kanemaru for importing medical equipment from USA. Specializes in importing and wholesaling medical equipment &
apparatus such as OR & Central Supply products, respiratory management
products, electro-surgical products, surgical instrumentation, gastrointestinal
products, MIS (Minimally Invasive Surgery) products, etc, etc. In 1991, separated the surgery division as a
wholly-owned entity, JSS Inc (see REGISTRATION), to focus on surgery medical
equipment, such as electro-surgical systems, surgical instrumentation,
other. On 01/08/2006, reorganized the
group as IMJ Group, with two pillar firms (divisions): Intermed Japan Inc and
JSS Inc. Both firms hold licenses for
importing medical instruments granted from the Ministry of Health, Labor &
Welfare, Japan as above stated. Goods
are imported from USA, Europe centrally.
Clients are medical institutions, medical equipment dealers, mfrs,
other, nationwide.
FINANCIAL INFORMATION
The sales volume for Oct/2005 fiscal term amounted to Yen 3,300 million, a 10% up from Yen 3,000 million in the previous term. This was thanks to increased demand for cardiac surgery-related equipment and apparatus. The net profit was posted at Yen 150 million, up 15% from Yen 130 million a year ago.
For the term ended Oct 2006 the net profit is
thought posted at Yen 160 million, on a 6% rise in turnover, to Yen 3,500
million. Final results have not been
made available.
The financial situation is considered FAIR and
good for ORDINARY business engagements.
Max credit limit is estimated at Yen 141.3 million, on 30 days normal
terms.
REGISTRATION
Date
Registered: Oct 1980
Legal
Status: Limited Company
(Kabushiki Kaisha)
Authorized: 240,000 shares
Issued: 60,000 shares
Sum: Yen 30 million
Major shareholders (%): Ken’ichi Kanemaru (52)
No. of shareholders: 8
Nothing
detrimental is known as to the commercial morality of executives.
*.. JSS Inc, at 8F of the caption address,
separated from the subject firm in May/1991 to focus
on import and wholesale of surgical medical instruments from V Mueller, USA;
Medical Instruments Importer/Distributor’s License: 27B1X00040 granted from the
Minister of Health, Labor and Welfare.
Management & operations, including domestic & overseas branch
offices, are fully integrated with the parent, Intermed Japan Inc.
URL: http://jss.co.jp
(Japanese only)
OPERATION
Activities: Imports and wholesales medical
equipment, apparatus, supplies (--100%); such as: Operating room products (gloves/non-woven), patient care
products, respiratory care products, surgical instruments, ligation systems,
medical instruments, electric surgical generation, feeding rubes/disposable
catheters, minimum invasive surgery products (MIS), surgical light sources,
surgical visual system, Cosgrove, endoscope, others
Clients: [Mfrs, wholesalers, hospitals] Nipro, Mutow Co, JSS Inc, Yagami Co, Hama Medical Ind, Kishiya, Masuda Ika Kikai, Towa Ika Kikai, other.
No. of
accounts: 500
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs, wholesalers] Timesco, EMS,
Unomidical, Hudson RCI, V Mueller, Ansell Healthcare, ConMed Corp, AcuLux,
Teleflex, Access Surgical, CV Medica, Bissinger, Nashville Surgical
Instruments, Conform, other from USA, Europe, etc.
Payment
record: Regular
Location: Business area in Osaka. Office premises at the caption address are
leased and maintained satisfactorily.
Bank References
Chugoku
Bank (Osaka)
Mizuho
Bank (Osaka-Chuo)
Relations:
Satisfactory
FINANCES
(In
Million Yen)
|
Terms Ending: |
31/10/2006 |
31/10/2005 |
31/10/2004 |
31/10/2003 |
|
|
Annual Sales |
|
3,500
|
3,300
|
3,000
|
3,150
|
|
Recur. Profit |
(*) |
|
625 |
210 |
|
|
Net Profit |
|
160 |
150 |
130 |
101 |
|
Total Assets |
|
|
3,900
|
|
3,210
|
|
Current Assets |
|
|
2,550
|
|
2,250
|
|
Current Liabs |
|
|
910 |
|
710 |
|
Net Worth |
|
|
2,700
|
|
2,500
|
|
Capital, Paid-Up |
|
|
30 |
30 |
30 |
|
<Analytical
Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
6.06 |
10.00
|
-4.76
|
5.07 |
|
|
Current Ratio |
|
.. |
280.22
|
.. |
316.90
|
|
N.Worth Ratio |
.. |
69.23
|
.. |
77.88
|
|
|
R.Profit/Sales |
|
.. |
.. |
.. |
13.65
|
|
N.Profit/Sales |
4.57 |
4.55 |
4.33 |
3.21 |
|
|
Return On Equity |
.. |
5.56 |
.. |
4.04 |
|
Note: Financials are disclosed only in
rounded-off figures. B/S’s are disclosed
for the 31/10/2005 & 31/10/2003 fiscal terms only.
Forecast
(or estimated) for the 31/10/2006 fiscal term.
(*)
Pretax profits disclosed from the Taxation Office.
|
Terms Ending: |
31/10/2006 |
31/10/2005 |
31/10/2004 |
31/10/2003 |
|
|
Annual Sales |
|
3,500 |
3,300 |
3,000 |
3,150 |
|
Recur. Profit |
|
|
|
|
430 |
|
Net Profit |
|
160 |
150 |
130 |
101 |
|
Total Assets |
|
|
3,900 |
|
3,210 |
|
Current Assets |
|
|
2,550 |
|
2,250 |
|
Current Liabs |
|
|
910 |
|
710 |
|
Net Worth |
|
|
2,700 |
|
2,500 |
|
Capital, Paid-Up |
|
|
30 |
30 |
30 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
6.06 |
10.00 |
-4.76 |
5.07 |
|
|
Current Ratio |
|
.. |
280.22 |
.. |
316.90 |
|
N.Worth Ratio |
.. |
69.23 |
.. |
77.88 |
|
|
R.Profit/Sales |
|
.. |
.. |
.. |
13.65 |
|
N.Profit/Sales |
4.57 |
4.55 |
4.33 |
3.21 |
|
|
Return On Equity |
.. |
5.56 |
.. |
4.04 |
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)